Johnson & Johnson news

   Watch this stock
Showing stories 1 - 10 of about 110   

Articles published

JNJ 98.47 -0.06 (-0.06%)
price chart
Has Johnson & Johnson's Stock Peaked?
Johnson & Johnson's stock has come down slightly from its peak value and has been more or less stable for a while in absence of any meaningful triggers.
Johnson & Johnson HIV Vaccine Can Block Virus In 50 Percent Of Monkeys In ...
Johnson & Johnson announced on July 2 that it has collaborated with an international team of experts to conduct a study and test the effectiveness of an HIV vaccine regimen on non-human primates.
HIV Vaccine from Johnson and Johnson Shows Promising Results in Non ...  The Standard Daily
Amazing results from AIDS vaccine test, Johnson & Johnson is now getting ...  Morning Ticker
5 Figures to Monitor Ahead of Johnson & Johnson's Second-Quarter Report
Johnson & Johnson (NYSE:JNJ) has the honor of essentially setting the tone for investors by being one of the first healthcare companies each quarter to report its earnings results.
3 Reasons Johnson & Johnson Stock Could Rise  Investopedia (registration)
3 Reasons Why Investors Should Keep Johnson & Johnson (JNJ) Stock  Zacks.com
How High Could Johnson & Johnson's Dividend Go?
For retirees, income investors, and those investors with a risk-averse investing style, chances are that healthcare conglomerate Johnson & Johnson (NYSE: JNJ) is a company you've considered, or rely on in your own investment or retirement portfolio.
Is Johnson & Johnson's Future on the Fast Track?  Motley Fool
Johnson & Johnson And The Supplemental Income Approach (JNJ)  Seeking Alpha
Johnson & Johnson Has a Dirty Secret About Microbeads
Instead of moving to safe, natural alternatives, Johnson & Johnson wants to replace plastic microbeads with more plastic.
FBI Investigating Johnson & Johnson Over Morcellators
PITTSBURGH (KDKA) - The FBI is now investigating Johnson & Johnson over a device used to treat thousands of women for a common problem.
Should I Buy Johnson & Johnson? 3 Pros and 3 Cons (JNJ)
Product Mix: Johnson & Johnson essentially has two sides to its business. It sells low-price, brand-name products like band aids, soaps and other health and beauty products.
One Put, One Call Option To Know About for Johnson & Johnson
So unless Johnson & Johnson sees its shares fall 6.3% and the contract is exercised (resulting in a cost basis of $91.27 per share before broker commissions, subtracting the $1.23 from $92.50), the only upside to the put seller is from collecting that ...
Better Dividend Stock: AbbVie or Johnson & Johnson?
As we all have to make tough investing choices, though, it can be difficult to decide which dividend payers to buy, especially among top dogs such as AbbVie (NYSE:ABBV) and Johnson & Johnson (NYSE:JNJ). These two healthcare companies have a ...
GlaxoSmithKline plc (ADR) Mega-Merger Talk: Johnson & Johnson, Roche ...
New takeover rumors for GlaxoSmithKline Plc. (ADR) (NYSE:GSK) emerged Monday. Daily Mail UK reported that UK dealers were speculating Roche Holding Ltd.